The medical device industry is an INCREDIBLY fertile hunting ground for growth stock investors.
Here are 10 innovative medical device makers that still have HUGE growth potential:
Here are 10 innovative medical device makers that still have HUGE growth potential:
1) Dermtech - $DMTK
What: Non-invasive skin cancer diagnosis
Stage: Commercial
Business Risk: High
Profitable? No, years away
What: Non-invasive skin cancer diagnosis
Stage: Commercial
Business Risk: High
Profitable? No, years away
2) Inspire Medical - $INSP
What: Implantable device that treats severe sleep apnea
Stage: Commercial
Business Risk: Med-High
Profitable? No, years away
What: Implantable device that treats severe sleep apnea
Stage: Commercial
Business Risk: Med-High
Profitable? No, years away
3) InMode $INMD
What: Minimally-invasive aesthetic surgery equipment
Stage: Commercial
Business Risk: Med
Profitable? Yes
What: Minimally-invasive aesthetic surgery equipment
Stage: Commercial
Business Risk: Med
Profitable? Yes
4) Plumonx $LUNG
What: Surgical product that treats severe emphysema
Stage: Commercial
Business Risk: High
Profitable? No, years away
What: Surgical product that treats severe emphysema
Stage: Commercial
Business Risk: High
Profitable? No, years away
5) Inari Medical - $NARI
What: Surgical tools to remove blood clots from veins
Stage: Commercial
Business Risk: Medium
Profitable? Yes
What: Surgical tools to remove blood clots from veins
Stage: Commercial
Business Risk: Medium
Profitable? Yes
6) Nano-X Imaging - $NNOX
What: ~100x reduction in the cost of Xray technology
Stage: R&D
Business Risk: VERY High
Profitable? No, years away
What: ~100x reduction in the cost of Xray technology
Stage: R&D
Business Risk: VERY High
Profitable? No, years away
7) Novocure - $NVCR
What: Uses electric fields to inhibit cell division in cancerous tumors
Stage: Commercial
Business Risk: Medium
Profitable? Yes
What: Uses electric fields to inhibit cell division in cancerous tumors
Stage: Commercial
Business Risk: Medium
Profitable? Yes
8) Outset Medical - $OM
What: Dramatic simplification of the equipment used in dialysis
Stage: Commercial
Business Risk: High
Profitable? No, years away
What: Dramatic simplification of the equipment used in dialysis
Stage: Commercial
Business Risk: High
Profitable? No, years away
9) Shockwave Medical - $SWAV
What: Surgical products that use shockwaves to improve blood flow in calcified arteries
Stage: Commercial
Business Risk: Medium
Profitable? No, but estimated to be in 2022
What: Surgical products that use shockwaves to improve blood flow in calcified arteries
Stage: Commercial
Business Risk: Medium
Profitable? No, but estimated to be in 2022
10) Transmedics - $TMDX
What: Keeps human organs alive longer during transportation, dramatically increasing supply
Stage: Commercial
Business Risk: High
Profitable? No, years away
What: Keeps human organs alive longer during transportation, dramatically increasing supply
Stage: Commercial
Business Risk: High
Profitable? No, years away
Will all of these work out for investors?
Of course not!
Many of them are VERY high-risk.
But, if just one turns out to be a big winner, it can pay for all of the losers combined
Of course not!
Many of them are VERY high-risk.
But, if just one turns out to be a big winner, it can pay for all of the losers combined
Which of these stocks interests you the most?
I’ll do a deep dive on it on my YouTube Channel
Subscribe here:
youtube.com/brianferoldiyt…
I’ll do a deep dive on it on my YouTube Channel
Subscribe here:
youtube.com/brianferoldiyt…
Summary:
1) $DMTK (skin cancer)
2) $INSP (sleep apnea)
3) $INMD (cosmetics)
4) $LUNG (emphysema)
5) $NARI (veins)
6) $NNOX (x-ray)
7) $NVCR (tumors)
8) $OM (dialysis)
9) $SWAV (cardiovascular)
10) $TMDX (organ transplant)
1) $DMTK (skin cancer)
2) $INSP (sleep apnea)
3) $INMD (cosmetics)
4) $LUNG (emphysema)
5) $NARI (veins)
6) $NNOX (x-ray)
7) $NVCR (tumors)
8) $OM (dialysis)
9) $SWAV (cardiovascular)
10) $TMDX (organ transplant)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
